Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries.

from US Top News and Analysis https://ift.tt/eHjzdaq
https://ift.tt/o9RiuHV